The joint association of glycated haemoglobin and low-density lipoprotein cholesterol with type 2 diabetic neuropathy
Neuropathy is highly prevalent and has a poor prognosis in type 2 diabetes mellitus (T2DM) patients. T2DM is accompanied by abnormal glucose and lipid metabolism. Glycated haemoglobin (HbA1c) is a risk factor with a limited regulatory role. The role of low-density lipoprotein cholesterol (LDL-C) also remains unclear. Here, we analysed the effects of HbA1c and LDL-C on type 2 diabetic neuropathy. Patients with T2DM with no baseline neuropathy were selected from the UK Biobank (UKB) database; 1,484 patients were enrolled based on a 12-year follow-up period. Patients were grouped according to their HbA1c levels(< 7%, 7–9%, and ≥ 9%) and their LDL-C levels (< 2.6 mmol/L and ≥ 2.6 mmol/L). Cox regression analysis revealed associations between HbA1c and LDL-C levels and the risk of type 2 diabetic neuropathy. Next, logistic regression was performed using clinical data from 611 patients with T2DM. We also analysed the interaction between LDL-C and HbA1c. After adjustment for confounding factors, compared with HbA1c < 7%, both HbA1c 7–9% and ≥ 9% were associated with an increased risk of type 2 diabetic neuropathy [HR = 1.62 (1.31–2.01); P < 0.001; HR = 2.44 (1.76–3.38); P < 0.001] in the UKB; compared with LDL-C < 2.6 mmol/L, LDL-C ≥ 2.6 mmol/L did not increase the risk of type 2 diabetic neuropathy [HR = 1.06(0.81–1.40); P = 0.675]. Compared with LDL-C ≥ 2.6 mmol/L combined with HbA1c < 7%, LDL-C ≥ 2.6 mmol/L combined with HbA1c ≥ 9% increased the risk of type 2 diabetic neuropathy [HR = 2.80 (1.76–4.48); P < 0.001]. Consistent findings were observed in the logistic regression analysis of clinical data and in sex-stratified analyses. HbA1c is an independent risk factor for neuropathy in patients with T2DM. LDL-C is not associated with type 2 diabetic neuropathy. However, in the context of suboptimal LDL-C control, extremely poor HbA1c control is closely associated with diabetic neuropathy than well controlled HbA1c.
Authors
- LiLan Wang (ORCID: https://orcid.org/0009-0001-7220-2504)
- Zixuan Ru
- Tianshu Han (ORCID: https://orcid.org/0000-0001-9596-4619)
- Kerou Li
- 张晓娜
- Hong Qiao (ORCID: https://orcid.org/0000-0002-4360-5881)
- Na Lv
- Nana Liang
- Shengnan Gao
- Minnan Wang
Institutions
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
- Heilongjiang Academy of Medical Sciences (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1038/s41598-026-80710-y
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00